Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Mar-24 4:30 PM View:  | Kastelein Johannes Jacob Pi... Chief Scientific Officer Director | Newamsterdam Pharma Co N.V. (NAMS) | 26-Mar-24 | Option Exercise | 201,673 | -- | -- | 100% 0 to 201.67K | |
| 28-Mar-24 4:30 PM View: | Topper James N Director | Newamsterdam Pharma Co N.V. (NAMS) | 26-Mar-24 | Market Purchase | 8,429 | $21.50 | $181,224.00 | < 1% 6.8M to 6.81M | (3%) |
| 27-Mar-24 4:30 PM View: | Kastelein Johannes Jacob Pi... Chief Scientific Officer Director | Newamsterdam Pharma Co N.V. (NAMS) | 26-Mar-24 | Option Sale | 190,476 | $21.50 | $4,095,230.00 | (100%) 190.48K to 0 | |
| 27-Mar-24 4:30 PM View: | Kastelein Johannes Jacob Pi... Chief Scientific Officer Director | Newamsterdam Pharma Co N.V. (NAMS) | 26-Mar-24 | Payment of Exercise | 11,197 | $22.72 | $254,396.00 | (6%) 201.67K to 190.48K | |
| 21-Feb-24 5:00 PM View: | Lange Louis G Director | Newamsterdam Pharma Co N.V. (NAMS) | 13-Feb-24 | Market Purchase | 5,000 | $19.00 | $95,000.00 | 25% 19.88K to 24.88K | 11% |
